» Articles » PMID: 31403469

Gut-derived GIP Activates Central Rap1 to Impair Neural Leptin Sensitivity During Overnutrition

Abstract

Nutrient excess, a major driver of obesity, diminishes hypothalamic responses to exogenously administered leptin, a critical hormone of energy balance. Here, we aimed to identify a physiological signal that arises from excess caloric intake and negatively controls hypothalamic leptin action. We found that deficiency of the gastric inhibitory polypeptide receptor (Gipr) for the gut-derived incretin hormone GIP protected against diet-induced neural leptin resistance. Furthermore, a centrally administered antibody that neutralizes GIPR had remarkable antiobesity effects in diet-induced obese mice, including reduced body weight and adiposity, and a decreased hypothalamic level of SOCS3, an inhibitor of leptin actions. In contrast, centrally administered GIP diminished hypothalamic sensitivity to leptin and increased hypothalamic levels of Socs3. Finally, we show that GIP increased the active form of the small GTPase Rap1 in the brain and that its activation was required for the central actions of GIP. Altogether, our results identify GIPR/Rap1 signaling in the brain as a molecular pathway linking overnutrition to the control of neural leptin actions.

Citing Articles

Differences in GIP Receptor Expression by Feeding Status in the Mouse Brain.

Song D, Jung N, Sung Y, Hong Y, Lee H Int J Mol Sci. 2025; 26(3).

PMID: 39940910 PMC: 11818402. DOI: 10.3390/ijms26031142.


Approved and Emerging Hormone-Based Anti-Obesity Medications: A Review Article.

Sidrak W, Kalra S, Kalhan A Indian J Endocrinol Metab. 2024; 28(5):445-460.

PMID: 39676791 PMC: 11642516. DOI: 10.4103/ijem.ijem_442_23.


Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance.

De Fano M, Malara M, Vermigli C, Murdolo G Int J Mol Sci. 2024; 25(16).

PMID: 39201336 PMC: 11354636. DOI: 10.3390/ijms25168650.


Role of short-chain fatty acids in host physiology.

Liu M, Lu Y, Xue G, Han L, Jia H, Wang Z Animal Model Exp Med. 2024; 7(5):641-652.

PMID: 38940192 PMC: 11528394. DOI: 10.1002/ame2.12464.


The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue.

Kagdi S, Lyons S, Beaudry J J Endocrinol. 2024; 261(3).

PMID: 38579777 PMC: 11103678. DOI: 10.1530/JOE-23-0361.


References
1.
Turcot V, Lu Y, Highland H, Schurmann C, Justice A, Fine R . Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet. 2017; 50(1):26-41. PMC: 5945951. DOI: 10.1038/s41588-017-0011-x. View

2.
Speliotes E, Willer C, Berndt S, Monda K, Thorleifsson G, Jackson A . Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010; 42(11):937-48. PMC: 3014648. DOI: 10.1038/ng.686. View

3.
Mroz P, Finan B, Gelfanov V, Yang B, Tschop M, DiMarchi R . Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism. Mol Metab. 2018; 20:51-62. PMC: 6358549. DOI: 10.1016/j.molmet.2018.12.001. View

4.
Regard J, Sato I, Coughlin S . Anatomical profiling of G protein-coupled receptor expression. Cell. 2008; 135(3):561-71. PMC: 2590943. DOI: 10.1016/j.cell.2008.08.040. View

5.
Finan B, Ma T, Ottaway N, Muller T, Habegger K, Heppner K . Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans. Sci Transl Med. 2013; 5(209):209ra151. DOI: 10.1126/scitranslmed.3007218. View